| Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19 Y Peng, AJ Mentzer, G Liu, X Yao, Z Yin, D Dong, W Dejnirattisai, ... Nature immunology 21 (11), 1336-1345, 2020 | 1209 | 2020 |
| Evidence of escape of SARS-CoV-2 variant B. 1.351 from natural and vaccine-induced sera D Zhou, W Dejnirattisai, P Supasa, C Liu, AJ Mentzer, HM Ginn, Y Zhao, ... Cell 184 (9), 2348-2361. e6, 2021 | 1145 | 2021 |
| SARS-CoV-2 Omicron-B. 1.1. 529 leads to widespread escape from neutralizing antibody responses W Dejnirattisai, J Huo, D Zhou, J Zahradník, P Supasa, C Liu, ... Cell 185 (3), 467-484. e15, 2022 | 940 | 2022 |
| Reduced neutralization of SARS-CoV-2 B. 1.617 by vaccine and convalescent serum C Liu, HM Ginn, W Dejnirattisai, P Supasa, B Wang, A Tuekprakhon, ... Cell 184 (16), 4220-4236. e13, 2021 | 763 | 2021 |
| Antibody evasion by the P. 1 strain of SARS-CoV-2 W Dejnirattisai, D Zhou, P Supasa, C Liu, AJ Mentzer, HM Ginn, Y Zhao, ... Cell 184 (11), 2939-2954. e9, 2021 | 658 | 2021 |
| Antibody escape of SARS-CoV-2 Omicron BA. 4 and BA. 5 from vaccine and BA. 1 serum A Tuekprakhon, R Nutalai, A Dijokaite-Guraliuc, D Zhou, HM Ginn, ... Cell 185 (14), 2422-2433. e13, 2022 | 620 | 2022 |
| Reduced neutralization of SARS-CoV-2 B. 1.1. 7 variant by convalescent and vaccine sera P Supasa, D Zhou, W Dejnirattisai, C Liu, AJ Mentzer, HM Ginn, Y Zhao, ... Cell 184 (8), 2201-2211. e7, 2021 | 491 | 2021 |
| Reduced neutralisation of SARS-CoV-2 omicron B. 1.1. 529 variant by post-immunisation serum W Dejnirattisai, RH Shaw, P Supasa, C Liu, ASV Stuart, AJ Pollard, X Liu, ... Lancet (London, England) 399 (10321), 234, 2022 | 369 | 2022 |
| The antigenic anatomy of SARS-CoV-2 receptor binding domain W Dejnirattisai, D Zhou, HM Ginn, HME Duyvesteyn, P Supasa, JB Case, ... Cell, 2021 | 359 | 2021 |
| An immunodominant NP105–113-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease Y Peng, SL Felce, D Dong, F Penkava, AJ Mentzer, X Yao, G Liu, Z Yin, ... Nature immunology 23 (1), 50-61, 2022 | 141 | 2022 |
| Potent cross-reactive antibodies following Omicron breakthrough in vaccinees R Nutalai, D Zhou, A Tuekprakhon, HM Ginn, P Supasa, C Liu, J Huo, ... Cell 185 (12), 2116-2131. e18, 2022 | 127 | 2022 |
| Convalescent plasma therapy for the treatment of patients with COVID‐19: assessment of methods available for antibody detection and their correlation with neutralising antibody … H Harvala, ML Robb, N Watkins, S Ijaz, S Dicks, M Patel, P Supasa, ... Transfusion Medicine 31 (3), 167-175, 2021 | 100 | 2021 |
| Oxford Immunology Network Covid-19 Response T cell Consortium; ISARIC4C Investigators. Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent … Y Peng, AJ Mentzer, G Liu, X Yao, Z Yin, D Dong, W Dejnirattisai, ... Nat. Immunol 21, 1336-1345, 2020 | 99 | 2020 |
| Detection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020 CP Thompson, NE Grayson, RS Paton, JS Bolton, J Lourenço, ... Eurosurveillance 25 (42), 2000685, 2020 | 80 | 2020 |
| High susceptibility to liver injury in IL‐27 p28 conditional knockout mice involves intrinsic interferon‐γ dysregulation of CD4+ T cells S Zhang, R Liang, W Luo, C Liu, X Wu, Y Gao, J Hao, G Cao, X Chen, ... Hepatology 57 (4), 1620-1631, 2013 | 77 | 2013 |
| Identification of a small molecule that simultaneously suppresses virulence and antibiotic resistance of Pseudomonas aeruginosa Q Guo, Y Wei, B Xia, Y Jin, C Liu, X Pan, J Shi, F Zhu, J Li, L Qian, X Liu, ... Scientific reports 6 (1), 19141, 2016 | 73 | 2016 |
| SuhB is a regulator of multiple virulence genes and essential for pathogenesis of Pseudomonas aeruginosa K Li, C Xu, Y Jin, Z Sun, C Liu, J Shi, G Chen, R Chen, S Jin, W Wu MBio 4 (6), 10.1128/mbio. 00419-13, 2013 | 72 | 2013 |
| PrtR homeostasis contributes to Pseudomonas aeruginosa pathogenesis and resistance against ciprofloxacin Z Sun, J Shi, C Liu, Y Jin, K Li, R Chen, S Jin, W Wu Infection and Immunity 82 (4), 1638-1647, 2014 | 54 | 2014 |
| Neutralising antibodies to SARS coronavirus 2 in Scottish blood donors-a pilot study of the value of serology to determine population exposure CP Thompson, N Grayson, R Paton, JS Bolton, J Lourenço, B Penman, ... | 53 | 2020 |
| The antibody response to SARS-CoV-2 Beta underscores the antigenic distance to other variants C Liu, D Zhou, R Nutalai, HME Duyvesteyn, A Tuekprakhon, HM Ginn, ... Cell Host & Microbe 30 (1), 53-68. e12, 2022 | 52 | 2022 |
Fang Flora BaiStanford Univeristy, Nankai University在 stanford.edu 的电子邮件经过验证
